Matches in SemOpenAlex for { <https://semopenalex.org/work/W1826607392> ?p ?o ?g. }
- W1826607392 endingPage "78" @default.
- W1826607392 startingPage "39" @default.
- W1826607392 abstract "Type 1 diabetes (T1D) in children and particularly in teenagers and adults is strongly associated with autoreactivity to the Mr 65,000 isoform of glutamic acid decarboxylase (GAD65). Autoantibodies to GAD65 are common at the time of clinical diagnosis and may be present for years prior to the onset of hyperglycemia. GAD65 autoantibodies predict conversion to insulin dependence when present in patients classified with type 2 diabetes nowadays more often referred to as patients with latent autoimmune diabetes in the adult (LADA) or type 1,5 diabetes. Analyses of T cells with HLA DRB1 0401-tetramers with GAD65-specific peptides as well as of anti-idiotypic GAD65 autoantibodies suggest that GAD65 autoreactivity is common. The immunological balance is disturbed and the appearance of GAD65 autoantibodies represents markers of autoreactive loss of pancreatic beta cells. Extensive experimental animal research, in particular of the Non-obese diabetic (NOD) mouse, showed that GAD65 therapies reduce insulitis and prevent spontaneous diabetes. Recombinant human GAD65 produced by current Good Manufacturing Practice (cGMP) and formulated with alum was found to be safe in Phase I and II placebo-controlled, double-blind, randomized clinical trials. The approach to modulate GAD65 autoreactivity with subcutaneous immunotherapy (SCIT) showed promise as alum-formulated GAD65 induced a dose-dependent reduction in the disappearance rate of endogenous residual C-peptide production. Additional controlled clinical trials are needed to uncover the mechanisms by which subcutaneous injections of recombinant human GAD65 may alter GAD65 autoreactivity." @default.
- W1826607392 created "2016-06-24" @default.
- W1826607392 creator A5008841181 @default.
- W1826607392 creator A5071917727 @default.
- W1826607392 date "2008-01-01" @default.
- W1826607392 modified "2023-10-10" @default.
- W1826607392 title "Chapter 3 GAD65 Autoimmunity—Clinical Studies" @default.
- W1826607392 cites W1521212256 @default.
- W1826607392 cites W1535809378 @default.
- W1826607392 cites W1569477387 @default.
- W1826607392 cites W1591766096 @default.
- W1826607392 cites W1635638240 @default.
- W1826607392 cites W1661585222 @default.
- W1826607392 cites W1925140590 @default.
- W1826607392 cites W1928233225 @default.
- W1826607392 cites W1972066210 @default.
- W1826607392 cites W1974547058 @default.
- W1826607392 cites W1977557304 @default.
- W1826607392 cites W1977962868 @default.
- W1826607392 cites W1978885851 @default.
- W1826607392 cites W1980705644 @default.
- W1826607392 cites W1981273749 @default.
- W1826607392 cites W1981858506 @default.
- W1826607392 cites W1981899305 @default.
- W1826607392 cites W1983016159 @default.
- W1826607392 cites W1983206326 @default.
- W1826607392 cites W1983864650 @default.
- W1826607392 cites W1986160442 @default.
- W1826607392 cites W1986205743 @default.
- W1826607392 cites W1986391431 @default.
- W1826607392 cites W1986753195 @default.
- W1826607392 cites W1987517811 @default.
- W1826607392 cites W1988220127 @default.
- W1826607392 cites W1990674646 @default.
- W1826607392 cites W1991294321 @default.
- W1826607392 cites W1992412559 @default.
- W1826607392 cites W1995575792 @default.
- W1826607392 cites W1996604774 @default.
- W1826607392 cites W1997222580 @default.
- W1826607392 cites W2003157922 @default.
- W1826607392 cites W2003571862 @default.
- W1826607392 cites W2007341485 @default.
- W1826607392 cites W2009596665 @default.
- W1826607392 cites W2011567860 @default.
- W1826607392 cites W2011658568 @default.
- W1826607392 cites W2013634083 @default.
- W1826607392 cites W2014228101 @default.
- W1826607392 cites W2014281671 @default.
- W1826607392 cites W2014540885 @default.
- W1826607392 cites W2015258305 @default.
- W1826607392 cites W2019972832 @default.
- W1826607392 cites W2021951643 @default.
- W1826607392 cites W2023417407 @default.
- W1826607392 cites W2024275584 @default.
- W1826607392 cites W2025690599 @default.
- W1826607392 cites W2025749474 @default.
- W1826607392 cites W2033481852 @default.
- W1826607392 cites W2036189966 @default.
- W1826607392 cites W2036850132 @default.
- W1826607392 cites W2039255704 @default.
- W1826607392 cites W2039440459 @default.
- W1826607392 cites W2039743782 @default.
- W1826607392 cites W2041412815 @default.
- W1826607392 cites W2041644002 @default.
- W1826607392 cites W2042321461 @default.
- W1826607392 cites W2043947355 @default.
- W1826607392 cites W2045385822 @default.
- W1826607392 cites W2045758494 @default.
- W1826607392 cites W2048114019 @default.
- W1826607392 cites W2049080353 @default.
- W1826607392 cites W2050578141 @default.
- W1826607392 cites W2052726638 @default.
- W1826607392 cites W2053004089 @default.
- W1826607392 cites W2053681756 @default.
- W1826607392 cites W2053703678 @default.
- W1826607392 cites W2055544904 @default.
- W1826607392 cites W2058861592 @default.
- W1826607392 cites W2059059809 @default.
- W1826607392 cites W2059144476 @default.
- W1826607392 cites W2060376087 @default.
- W1826607392 cites W2060721242 @default.
- W1826607392 cites W2061076168 @default.
- W1826607392 cites W2061327890 @default.
- W1826607392 cites W2066887417 @default.
- W1826607392 cites W2071416749 @default.
- W1826607392 cites W2072652145 @default.
- W1826607392 cites W2073914658 @default.
- W1826607392 cites W2075636902 @default.
- W1826607392 cites W2077114865 @default.
- W1826607392 cites W2081002064 @default.
- W1826607392 cites W2081580406 @default.
- W1826607392 cites W2084685705 @default.
- W1826607392 cites W2085690625 @default.
- W1826607392 cites W2087849403 @default.
- W1826607392 cites W2088684668 @default.
- W1826607392 cites W2091765481 @default.
- W1826607392 cites W2092251693 @default.
- W1826607392 cites W2094108596 @default.